Fevincio Tablet contains Ferric Citrate (210mg) as its active ingredient and is primarily used to manage iron deficiency anemia, particularly in patients with chronic kidney disease undergoing dialysis. Ferric Citrate acts as an effective phosphate binder and iron supplement, helping to increase serum iron levels and improve hemoglobin production. By binding dietary phosphate in the gastrointestinal tract, it reduces phosphate absorption, thereby controlling hyperphosphatemia, a common complication in kidney disease. Fevincio is typically prescribed to patients who require iron supplementation but cannot tolerate or absorb oral iron salts effectively. The tablet should be taken as directed by a healthcare professional, usually with meals to enhance absorption and minimize gastrointestinal discomfort. Common side effects may include mild gastrointestinal symptoms such as nausea, constipation, or diarrhea, but these are generally transient. Patients should inform their doctor if they experience severe side effects or allergic reactions. Fevincio Tablet is contraindicated in individuals with known hypersensitivity to ferric citrate or other iron-containing products. Regular monitoring of serum phosphate, iron levels, and hemoglobin is recommended during treatment to ensure optimal therapeutic outcomes and adjust dosage accordingly. This medication should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.